Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Yole Développement Announces New Technology & Market Analysis

Published: Monday, June 10, 2013
Last Updated: Sunday, June 09, 2013
Bookmark and Share
“Microfluidic applications in the pharmaceutical, life sciences, in vitro diagnostic and medical device markets, a new report from Yole Développement.

Yole Développement has announced its new technology & market analysis: Microfluidic applications in the pharmaceutical, life sciences, in vitro diagnostic and medical device markets.

With this report, Yole Développement proposes users to learn more about the microfluidic devices market. “The microfluidic device market will grow swiftly, from $1.4B in 2013 to $5.7B by 2018”, announces Benjamin Roussel, Technology & Market Analyst, Microfluidics & Medical Technologies at Yole Développement.

According to him, “This impressive 27% growth will be fueled mainly by pharmaceutical research and point-of-care applications”.

The microfluidic device market is expected to reach $5.7B by 2018!
Facing new challenges, the healthcare industry is currently moving toward personalized medicine. In this context, the line between traditional markets (pharmaceutical and in vitro diagnostic markets) has blurred. More than ever, rapid, accurate tests are needed to increase pharmaceutical research yield and better monitor/cure patients.

By offering innovative solutions, microfluidic technologies have successfully managed to fill the gap. This new Yole Développement report provides a complete analysis of microfluidic device markets and technologies.

Based on an accurate investigation of the last three years’ events, this report consolidates market data from 2010 - 2012 and provides forecasts for 2013 - 2018.

Microfluidic devices can be produced either by pure microfluidics fabs or in-house by fully integrated players. After revealing the top 15 pure microfluidic fab players, the report looks at the “hidden” market linked to in-house production.

These microfluidic devices can either be used directly for some applications (analytical devices, flow chemistry, etc.) or must be completed by reagents/biological content.

The distinction between the microfluidic device market (first-level package device) and the microfluidic technology-based test market has also been calculated.

Discover the microfluidic market’s complex organization, broken down in nine segments
Today, microfluidic devices are widely accepted in several applications. Nevertheless, the advantages and motivations for adopting microfluidic technologies are highly-dependent on the targeted application.

For example, the added value of microfluidic devices in point-of-care applications depends on the associated small volume of necessary reagents, low-cost disposables and high sensibility.

Contrarily, the advantages for pharmaceutical research applications are to allow process automation and multiplexed assays.

This report provides a market segmentation covering the following applications: general dispensing - drug delivery - accurate dispensing - analytical devices - clinical and veterinary diagnostics - point-of-care testing - industrial and environmental testing - pharmaceutical and life science - microreaction technology.

Each application is presented with market data, trends/drivers, key players and technologies used.

Recent changes in the material mix provide new opportunities for polymer and silicon
Different materials are used to manufacture microfluidic devices: glass, polymer, silicon, metal and ceramics.

Whereas polymer is becoming the reference substrate for point-of-care applications, glass is still the main substrate for analytical devices. The penetration rate of each substrate vs. Microfluidic application is presented in this report.

Recently, the material mix has changed due to:
• The need to reduce device cost for some applications (i.e. switching from glass to polymer)
• The need to add new on-chip functions linked to emerging applications (i.e. growth of silicon use)

Material mix changes present exciting opportunities for new players entering the microfluidic market. For example, the high growth rate of next-generation sequencing technologies is opening new doors for silicon players.

This report provides an analysis of these new opportunities, in line with material mix changes.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Yole Développement Announces Foundation of BLUMORPHO
BLUMORPHO will create value from innovation.
Tuesday, February 17, 2015
Evaluate the Manufacturing Cost of MEMS Devices with Cost Analysis Tool
Yole Développement and its partner, System Plus Consulting propose a relevant tool to analysis MEMS manufacturing cost.
Thursday, September 10, 2009
Yole Announces LifeScienceIC Report and Business Convention at EuroBIO 2006
The Business Convention Innovation Dating "When Micro & Nanotechnologies meet Life Sciences Industry", on Friday October 27th.
Monday, October 02, 2006
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos